Loading institutional data...
Loading institutional data...
Held by 573 of 6,047 reporting institutions (97th percentile) — extremely crowded.
Data as of Q2 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $108.88 today, the market must believe free cash flow compounds 3.0%/yr for a decade (off $855.3M on the 3-yr avg basis).
On the basis ($815.0M) the requirement is 3.7%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 3.0% is more conservative than its 7-yr track record.
Default is 8.0% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.11B shares (market data) · net debt $4.72B
mean 73.2% · volatility σ 271% · implied rate exceeded in 3/6 yrs
Central path = implied 3.0%/yr growth; shaded band = ±1σ (271%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-06-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PH | $119.4B | 33.3× | 23.4× | 5.5× | 8.3% | 37.7% | 17.0% | 23.7% | 15.5% | 1.4× | 1,912 |
| AXON | $33.9B | 276.4× | — | 12.2× | 33.5% | 59.7% | 4.5% | 3.8% | 2.5% | — | 1,090 |
| SNA | $18.6B | 18.7× | 12.7× | 3.6× | 0.9% | — | 19.7% | 17.1% | 14.3% | -0.3× | 1,027 |
| BALL | $15.5B | 17.7× | — | 1.2× | 11.6% | — | 7.0% | 16.9% | 16.8% | — | 778 |
| MAS | $13.7B | 18.0× | 11.5× | 1.8× | -3.4% | 35.4% | 10.7% | -438% | 29.3% | 1.6× | 875 |
| SWK | $13.5B | 33.6× | — | 0.9× | -1.5% | 30.3% | 2.7% | 4.4% | 2.8% | — | 759 |
| CCK | $11.8B | 17.1× | 8.9× | 1.0× | 4.8% | — | 6.0% | 24.6% | 8.7% | 2.5× | 573 |
| CR | $11.7B | 32.3× | 26.0× | 5.1× | 8.2% | 42.2% | 15.9% | 17.8% | 11.4% | 1.4× | 574 |
| WTS | $11.6B | 34.1× | 22.5× | 4.8× | 8.3% | 49.5% | 14.0% | 16.8% | 15.3% | -0.4× | 555 |
| VMI | $9.0B | 27.9× | 19.2× | 2.2× | 0.7% | 30.2% | 8.5% | 21.5% | 14.4% | 1.2× | 624 |
| ACA | $7.2B | 34.5× | 15.1× | 2.5× | 12.2% | 22.4% | 7.2% | 7.9% | 5.0% | 2.3× | 408 |
| SSD | $7.0B | 20.9× | 12.7× | 3.0× | 4.5% | 45.9% | 14.8% | 17.0% | 14.7% | -0.1× | 466 |
| MTRN | $5.8B | 77.4× | 34.7× | 3.2× | 6.0% | 17.3% | 4.2% | 7.9% | 5.3% | 2.5× | 391 |
| GEF | $4.7B | — | 13.8× | 1.2× | -9.7% | 22.2% | 21.4% | 28.8% | 20.4% | 2.3× | 277 |
| GFF | $4.2B | 84.5× | — | 1.7× | -3.9% | 42.0% | 2.0% | 69.1% | 3.4% | — | 330 |
Peers = companies sharing CCK's sector (Metal Cans) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 11% of free cash flow, leaving room to grow it and fund buybacks. Last year: $120.0M dividends + $505.0M buybacks = $625.0M returned on $1.12B FCF.
5 consecutive years of dividend increases · 6%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 9%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-08
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.37B 100.0% | $11.80B 100.0% | $12.01B 100.0% | $12.94B 100.0% | $11.39B 100.0% | $9.39B 100.0% | $11.66B 100.0% | $11.15B 100.0% | $8.70B 100.0% | $8.28B 100.0% |
| Cost of Products | — | — | — | — | — | — | — | $9.03B 81.0% | $7.01B 80.5% | $6.62B 79.9% |
| Research & Development | $33.0M 0.3% | $32.0M 0.3% | $33.0M 0.3% | $34.0M 0.3% | $47.0M 0.4% | $48.0M 0.5% | $50.0M 0.4% | $51.0M 0.5% | $39.0M 0.4% | $41.0M 0.5% |
| Selling, General & Admin | $632.0M 5.1% | $597.0M 5.1% | $582.0M 4.8% | $556.0M 4.3% | $583.0M 5.1% | $533.0M 5.7% | $556.0M 4.8% | $558.0M 5.0% | $367.0M 4.2% | $366.0M 4.4% |
| Operating Income | $1.55B 12.6% | $1.42B 12.0% | $1.27B 10.6% | $1.34B 10.3% | $1.36B 12.0% | $1.05B 11.2% | $1.03B 8.8% | $1.10B 9.8% | $1.02B 11.8% | $997.0M 12.0% |
| Interest Expense | $398.0M 3.2% | $452.0M 3.8% | $436.0M 3.6% | $284.0M 2.2% | $253.0M 2.2% | $290.0M 3.1% | $367.0M 3.1% | $384.0M 3.4% | $252.0M 2.9% | $243.0M 2.9% |
| Interest & Investment Income | $55.0M 0.4% | $82.0M 0.7% | $53.0M 0.4% | $15.0M 0.1% | $9.0M 0.1% | $8.0M 0.1% | $15.0M 0.1% | $21.0M 0.2% | $15.0M 0.2% | $12.0M 0.1% |
| Pretax Income | $1.16B 9.4% | $743.0M 6.3% | $795.0M 6.6% | $1.06B 8.2% | -$419.0M -3.7% | $725.0M 7.7% | $631.0M 5.4% | $740.0M 6.6% | $829.0M 9.5% | $769.0M 9.3% |
| Income Tax Expense | $281.0M 2.3% | $183.0M 1.6% | $222.0M 1.8% | $243.0M 1.9% | -$57.0M -0.5% | $199.0M 2.1% | $136.0M 1.2% | $216.0M 1.9% | $401.0M 4.6% | $186.0M 2.2% |
| Net Income | $738.0M 6.0% | $424.0M 3.6% | $450.0M 3.7% | $727.0M 5.6% | -$560.0M -4.9% | $579.0M 6.2% | $510.0M 4.4% | $439.0M 3.9% | $323.0M 3.7% | $496.0M 6.0% |
| Per Share | ||||||||||
| EPS (Basic) | $6.41 | $3.56 | $3.77 | $6.01 | -$4.30 | $4.34 | $3.81 | $3.28 | $2.39 | $3.58 |
| EPS (Diluted) | $6.38 | $3.55 | $3.76 | $5.99 | -$4.30 | $4.30 | $3.78 | $3.28 | $2.38 | $3.56 |
| Weighted Avg Shares (Basic) | 115.2M | 119.2M | 119.4M | 120.9M | 130.4M | 133.5M | 133.9M | 133.6M | 135.3M | 138.5M |
| Weighted Avg Shares (Diluted) | 115.7M | 119.4M | 119.7M | 121.4M | 130.4M | 134.6M | 134.9M | 133.9M | 135.6M | 139.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-08
Where each multiple sits in its own 14-yr range · 48th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 25% against ROIC 9% — 16% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 25.6% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.0× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| R&D | 0.5 | 0.4 | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 |
| SG&A | 5.0 | 4.8 | 5.7 | 5.1 | 4.3 | 4.8 | 5.1 | 5.1 |
| Operating Income | 9.8 | 8.8 | 11.2 | 12.0 | 10.3 | 10.6 | 12.0 | 12.6 |
| Income Tax | 1.9 | 1.2 | 2.1 | -0.5 | 1.9 | 1.8 | 1.6 | 2.3 |
| Net Income | 3.9 | 4.4 | 6.2 | -4.9 | 5.6 | 3.7 | 3.6 | 6.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CCK: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $764.0M covers the $480.0M due within a year 1.6× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~7.3% on $5.48B of debt.
Cash of $764.0M fully covers short-term debt of $83.0M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Earns 5.94pts above its cost of capital, positive in 5 of the last 5 years.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 8.1% | 8.0% (today's — no rate published for this year) | 0.1pts |
| FY2020 | 8.2% | 8.0% (today's — no rate published for this year) | 0.2pts |
| FY2021 | 12.8% | 6.2% | 6.6pts |
| FY2022 | 11.5% | 7.0% | 4.5pts |
| FY2023 | 11.4% | 7.9% | 3.5pts |
| FY2024 | 12.6% | 7.5% | 5.0pts |
| FY2025 | 14.1% | 6.8% | 7.3pts |
| Now | 8.7% | 8.0% | 0.7pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | 12.0% | 6.0% |
| FY2017 | not reported | 11.8% | 3.7% |
| FY2018 | not reported | 9.8% | 3.9% |
| FY2019 | not reported | 8.8% | 4.4% |
| FY2020 | not reported | 11.2% | 6.2% |
| FY2021 | not reported | 12.0% | -4.9% |
| FY2022 | not reported | 10.3% | 5.6% |
| FY2023 | not reported | 10.6% | 3.7% |
| FY2024 | not reported | 12.0% | 3.6% |
| FY2025 | not reported | 12.6% | 6.0% |
Leverage and buybacks account for 16 points of the 25% return on equity in FY2025. The business earns 9% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$3.1B of goodwill — 38% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
ROIC ex-goodwill is 22.47% against 13.96% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 1.22x of reported profit into free cash flow over 5 years, with accruals negative.
The cash conversion cycle could not be computed — receivables, inventory or cost of revenue is not reported — so the earliest accrual warning is not part of this verdict.
Covers interest 2.7x under stress — adequate, without much room.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 3.90x |
| 5% | 3.71x |
| 10% | 3.51x |
| 15% | 3.32x |
| 20% | 3.12x |
| 25% | 2.93x |
| 30% | 2.73x |
| 35% | 2.54x |
| 40% | 2.34x |
| 45% | 2.15x |
| 50% | 1.95x |
| 55% | 1.76x |
| 60% | 1.56x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $108.88, free cash flow must compound 3.2%/yr for 10 years. It has done 6.35%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −1.4% | 3.2% |
| FY2021 | −88.3% | 3.2% |
| FY2022 | −140.4% | 3.2% |
| FY2024 | 19.5% | 3.2% |
| FY2025 | 41.6% | 3.2% |
The implied rate has been matched or beaten in 2 of the last 5 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $738M | $738M |
| Share-based comp | $48M | $786M |
| Other non-cash & working capital | $744M | $1.53B |
| Operating cash flow | $1.53B | $1.53B |
| Capex | −$413M | $1.12B |
| Free cash flow | $1.12B | $1.12B |
| FCF after SBC | $1.07B | $1.07B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -19.5% | not reported | not reported |
| FY2021 | 21.3% | not reported | not reported |
| FY2022 | 13.6% | not reported | not reported |
| FY2023 | -7.2% | -1.5% | 5.7 points |
| FY2024 | -1.7% | -5.8% | -4.0 points |
| FY2025 | 4.8% | -0.7% | -5.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | not reported | not reported | not reported | not reported |
| FY2020 | not reported | not reported | not reported | not reported |
| FY2021 | not reported | not reported | not reported | not reported |
| FY2022 | 31.3 days | not reported | not reported | not reported |
| FY2023 | 33.2 days | not reported | not reported | not reported |
| FY2024 | 31.9 days | not reported | not reported | not reported |
| FY2025 | 30.2 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -5.1 percent |
| FY2020 | -4.4 percent |
| FY2021 | -10.6 percent |
| FY2022 | -0.5 percent |
| FY2023 | -6.7 percent |
| FY2024 | -5.5 percent |
| FY2025 | -5.5 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.